Antibody Technology definition

Antibody Technology means, with respect to a Collaboration Antigen, all Information and inventions, whether or not patented or patentable, which (a) relate to the Exploitation of antibodies, and either (i) (A) are Reasonably Necessary to be utilized by or on behalf of ABX under the Research Program for such Collaboration Antigen, or (B) are utilized by or on behalf of ABX under the Research Program or Development Program for such Collaboration Antigen, or (b) relate to the Exploitation of antibodies generally and are first conceived or generated under the Research Program for such Collaboration Antigen; provided, however, that Antibody Technology shall exclude Antigen-Specific Technology, Collaboration Technology, Additional Development Program Technology, Development Program Technology, Oncology Technology, Process Technology and XenoMouse Technology.
View Source
Antibody Technology means all rights to the Antibodies including, but not limited to:
View Source
Antibody Technology means any and all (a) OncoMed Know-How that is [***], as described on Schedule 1.6, and (b) [***], that in each case are [***] in the course of [***].
View Source

Examples of Antibody Technology in a sentence

  • Cambridge Antibody Technology Limited ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ The ▇▇▇▇▇▇▇▇ Building Cambridge, MA 02139 Granta Park, Cambridge Attention: Chief Executive Officer ▇▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇ Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ United Kingdom Attention: Company Secretary Facsimile: ▇▇▇-▇▇-(▇)▇▇▇▇ ▇▇▇▇▇▇ Either party may change its designated address and facsimile number by notice to the other party in the manner provided in this Clause.

  • Subject to the rights and licenses granted to Spyre in this Agreement, as between the Parties, Paragon or its Affiliates shall own all right, title and interest in and to all Project Antibody Technology, irrespective of inventorship.

  • MORPHOSYS will be responsible for license fees and milestone and royalty payments owed to XOMA Ireland Limited (“XOMA”), Cambridge Antibody Technology LTD (“CAT”) and The ▇▇▇▇▇ ▇▇▇▇▇▇▇ University (“JHU”), to the extent that the patent rights are accessed through (i) the XOMA License Agreement, (ii) the CAT Framework Agreement, and (iii) the JHU License Agreement.

  • During the Term of this Agreement, each Party may disclose to the other Party proprietary information, materials and technical and business information, including but not limited to MORPHOSYS Technology, CENTOCOR Technology, HuCAL Antibody Technology (including HuCAL Antibodies), and Licensed Products (collectively, “Confidential Information”).

  • Spyre shall have the right to reference any relevant data included within the Licensed Antibody Technology for the purposes of regulatory filings and safety reporting, including all nonclinical data, pre-approval and post-approval clinical use data, and regulatory data with respect thereto, and Paragon shall cooperate as reasonably requested by Spyre with respect to providing to Spyre when requested, and on a timely basis, any of the foregoing information, data filings or reporting.

  • Novartis hereby grants to Buyer the benefits of the covenant-not-to-▇▇▇ (“CAT Covenant”) under a framework agreement between Morphosys and Cambridge Antibody Technology (“CAT Framework Agreement”), with regard to the “CAT Patent Rights” described in Appendix 3.02 of the CAT Framework Agreement, in order to permit Buyer to practice any licenses granted to it herein by Novartis.

  • MORPHOSYS shall not prepare, file or prosecute any patent applications directed to HuCAL Antibody Technology not referred to in this Section 8.1.1, without the written consent of CENTOCOR.

  • MORPHOSYS Technology and HuCAL Antibody Technology shall be owned by MORPHOSYS.

  • Notwithstanding anything to the contrary under this Agreement, Paragon retains rights under the Licensed Antibody Technology solely to perform its obligations and exercise its rights under this Agreement and the Option Agreement.

  • Subject to the terms and conditions of this Agreement, on a Research Program-by-Research Program basis, and effective only during the Term, Paragon hereby grants to Spyre a limited, exclusive, royalty-free license, without the right to sublicense, under the Project Antibody Technology arising from such Research Program solely to evaluate the Option and for the purpose of allowing Spyre to determine whether to exercise the Option with respect to such Research Program.


More Definitions of Antibody Technology

Antibody Technology means the Antibody Patents and the Antibody Know-How, including any right, title and interest in any Improvements Controlled by or assigned to ▇▇▇▇▇ pursuant to any term of this Agreement.
View Source

Related to Antibody Technology

  • Program Technology means Program Know-How and Program Patents.

  • Product Technology means the Product Know-How and Product Patents.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Licensor Technology means the Licensor Patents and the Licensor Know-How.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.